Sph-biocad (hk) Limited

This study tested a new drug, netakimab, in 202 Chinese adults with moderate to severe plaque psoriasis. The goal was to see if it works better than a placebo at clearing skin symptoms. Results showed that more people taking netakimab achieved significant skin improvement by week…

This study tested a drug called netakimab in 113 Chinese adults with active ankylosing spondylitis, a type of arthritis that causes back pain and stiffness. Participants received either netakimab or a placebo as a shot under the skin. The main goal was to see if netakimab could r…